# Increase of macrolide resistance among Streptococcus pyogenes pharyngitis driven by a mef(A)-msr(D)/emm2-ST55 lineage in Portugal (2014–2019)

**Authors:** Ana Friães, Rafael Mamede, Beatriz Santos, Gina Marrão, José Melo-Cristino, Mario Ramirez

PMC · DOI: 10.1128/aac.00968-25 · Antimicrobial Agents and Chemotherapy · 2025-10-10

## TL;DR

This study tracks the rise of macrolide-resistant Streptococcus pyogenes in Portugal, showing how a specific lineage became dominant in 2019.

## Contribution

Identifies a new mef(A)-msr(D)/emm2-ST55 lineage driving increased macrolide resistance in pharyngitis cases in Portugal.

## Key findings

- Macrolide resistance peaked at 9% in 2019 due to the rapid spread of mef(A)-msr(D)-positive emm2-ST55 isolates.
- Resistant isolates showed lower genetic diversity and minimal overlap with susceptible lineages.
- Tetracycline resistance was commonly linked to tet(M) and tet(O) genes co-located with erm genes.

## Abstract

Increases in macrolide resistance occurred recently among Streptococcus pyogenes (Group A Streptococcus, GAS) in some countries. While the importance of monitoring the clinical and molecular epidemiology of non-invasive GAS is increasingly recognized, most surveillance focuses on invasive infections, since culture is rarely performed in tonsillo-pharyngitis. We determined the antimicrobial susceptibility and characterized the macrolide-resistant lineages of 2,002 pharyngeal isolates recovered in a Portuguese hospital in 2014–2019. There were seasonal variations in the numbers of recovered isolates, with peaks shifting between March–July and October–December, but consistently low numbers in August and September. Macrolide-resistant and macrolide-susceptible GAS presented independent seasonal and clonal dynamics, with resistant isolates showing lower genetic diversity and minimal overlap with susceptible lineages. Overall, 84 (4%), 77 (4%), and 52 (3%) isolates were resistant to erythromycin, clindamycin, and tetracycline, respectively. Until 2018, macrolide resistance was mainly due to an internationally disseminated emm77-ST63 lineage carrying erm(A) and tet(O) in ICESp2905 and an emm75-ST49 lineage carrying mef(A)-msr(D) in a novel ɸ1207.3 variant. In 2019, resistance peaked at 9% due to the rapid expansion of mef(A)-msr(D)-positive emm2-ST55 isolates, replacing previous lineages. Other minor resistant lineages carried mostly erm(B) in a diversity of mobile genetic elements, including emm75-ST150, emm9-ST75, emm11-ST403, emm12-ST36, emm76-ST50, and emm77-ST399 [erm(T)]. Tetracycline resistance was associated with the genes tet(M) and tet(O), in most cases co-located in the same genetic elements as the erm genes. This study reveals clonal changes among macrolide-resistant GAS driving fluctuations in macrolide resistance and associated phenotypes.

## Linked entities

- **Genes:** mef(A) (macrolide efflux MFS transporter Mef(A)) [NCBI Gene 45217682], msr(D) (ABC-F type ribosomal protection protein Msr(D)) [NCBI Gene 45217681], TMEM94 (transmembrane protein 94) [NCBI Gene 9772], tet(O) (tetracycline resistance ribosomal protection protein Tet(O)) [NCBI Gene 8154417], erm(B) (23S rRNA (adenine(2058)-N(6))-methyltransferase Erm(B)) [NCBI Gene 8154416], tet(M) (tetracycline resistance ribosomal protection protein Tet(M)) [NCBI Gene 8154447]
- **Chemicals:** erythromycin (PubChem CID 12560), clindamycin (PubChem CID 446598), tetracycline (PubChem CID 54675776)
- **Diseases:** pharyngitis (MONDO:0002258)
- **Species:** Streptococcus pyogenes (taxon 1314)

## Full-text entities

- **Diseases:** pharyngitis (MESH:D010612), infections (MESH:D007239)
- **Chemicals:** Tetracycline (MESH:D013752), clindamycin (MESH:D002981), Macrolide (MESH:D018942), erythromycin (MESH:D004917)
- **Species:** Streptococcus pyogenes (species) [taxon 1314], Streptococcus sp. 'group A' (species) [taxon 36470], Gastromermis sp. AS (species) [taxon 211381]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12587576/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12587576/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC12587576/full.md

---
Source: https://tomesphere.com/paper/PMC12587576